StemGenex® Announces Newest Stem Cell Treatment for COPD Patients - Hawaii News Now - KGMB and KHNL

StemGenex® Announces Newest Stem Cell Treatment for COPD Patients

  • HealthMore>>

  • FDA to propose e-cigarette regulations

    FDA to propose e-cigarette regulations

    © FDA© FDA
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
  • People seek out health info when famous person dies

    People seek out health info when famous person dies

    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
  • 1 in 13 U.S. schoolkids takes psych meds

    1 in 13 U.S. schoolkids takes psych meds

    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>
    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE StemGenex

StemGenex is now providing access to its latest stem cell therapy for patients diagnosed with COPD through nebulized stem cells. These treatments are being studied with expertise by board certified MD's in the United States.

LA JOLLA, Calif., Feb. 11, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases, today announced the newest therapy to assist patients diagnosed with COPD.

Leaders in US Stem Cell Therapy, StemGenex (800) 609-7795

COPD affects an estimated 9-10% of the world's entire population and is the 4th most common cause of death in the United States.  StemGenex believes a new therapy delivering adipose derived mesenchymal cells directly to the inflamed lungs may reduce the complications associated with COPD including shortness of breath, coughing, heart problems and more. 

Direct lung targeting is the latest in a series of newly developed therapies StemGenex® has announced over the past few months for patients dealing with degenerative diseases such as Parkinson's, Alzheimer's, Multiple Sclerosis and of course COPD.  This targeted therapy is accomplished by nebulizing the stem cells down to a mist so that patients can painlessly breathe the stem cells directly into their lungs.  The goal of this new technique is to encourage more stem cells to travel directly to the inflamed tissue of the lungs.

Stem cell treatment studies are currently being offered by StemGenex to patients diagnosed with COPD and degenerative neurological diseases.  StemGenex takes a unique approach of compassion and empowerment while providing access to the latest stem cell therapies for degenerative neurological diseases including Parkinson's and Alzheimer's disease, stroke recovery and others.  Rita Alexander, founder of StemGenex and the company's first stem cell patient, insists that all patients be treated like they are one of our loved ones.  "Hope, compassion, and the relentless pursuit for an end to these diseases are our primary focus."

To find out more about stem cell therapy, contact StemGenex either by phone at (800) 609-7795 or email Contact@stemgenex.com.

Related Links
www.stemgenex.com

Multimedia Assets associated with this release:
Photo: http://photos.prnewswire.com/prnh/20140211/LA60980

©2012 PR Newswire. All Rights Reserved.